Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
718
Total Claims
$1.0M
Drug Cost
165
Beneficiaries
$6,281
Cost/Patient
Risk Score Breakdown 7/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+66%
Opioid rate vs peers
10.4% vs 6.3% avg
-54%
Cost per patient vs peers
$6,281 vs $14K avg
-23%
Brand preference vs peers
11.3% vs 14.6% avg
Opioid Prescribing
10.4%
Opioid Rate
75
Opioid Claims
$5,257
Opioid Cost
46.7%
Long-Acting Rate
Brand vs Generic
Brand: 81 claims · $942K
Generic: 637 claims · $94K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Ibrutinib | 19 | $239K |
| Ruxolitinib Phosphate | 12 | $224K |
| Abiraterone Acetate | 36 | $72K |
| Apixaban | 11 | $6,245 |
| Fentanyl | 17 | $2,609 |
| Tamoxifen Citrate | 57 | $1,796 |
| Megestrol Acetate | 12 | $971 |
| Prochlorperazine Maleate | 42 | $817 |
| Hydroxyurea | 23 | $772 |
| Anastrozole | 36 | $759 |
| Morphine Sulfate | 16 | $691 |
| Oxycodone Hcl | 31 | $676 |
| Dexamethasone | 45 | $553 |
| Ondansetron Hcl | 50 | $396 |
| Letrozole | 31 | $388 |
Prescribing Profile
Patient Profile
74
Avg Age
64%
Female
1.64
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About